DNLI — Denali Therapeutics Inc. stock price, charts and financials

QT46Denali Therapeutics Inc.

Denali Therapeutics Inc. (NASDAQ: DNLI) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
19.72
-0.41-2.04%
OverviewShort InterestFilings
DNLIQT46Denali Therapeutics Inc.·NASDAQ
19.72-2.04%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 09, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 13, 20264Statement of changes in beneficial ownership
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Aug 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 28, 20268-KCurrent report
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 18, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
May 22, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 442
Page
▼
/ 18